1.
Hasle H, Juul-Dam KL. Maximal benefit of minimal residual disease monitoring in pediatric acute myeloid leukemia. haematol [Internet]. 2024Mar.1 [cited 2024Jun.13];109(3):701-3. Available from: https://haematologica.org/article/view/haematol.2023.283765